相关实验视频

Updated: May 14, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

乳腺癌中的内免疫疗法

Camille C Baumrucker¹, Nicole Harris², Susan Hoover²

¹Clinical Science Division, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.

|May 7, 2025

概括

内免疫疗法通过调节瘤微环境,为克服乳腺癌治疗耐药性提供了一个有希望的策略. 本综述探讨了各种免疫疗法及其对晚期乳腺癌的临床应用.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
癌症研究癌症研究

背景情况:

乳腺癌是女性癌症死亡的主要原因,转移性复发构成重大治疗挑战.
传统疗法通常对抗耐药转移性乳腺癌是无效的,这凸显了对新型治疗方法的需求.
免疫疗法利用身体的免疫系统,已成为癌症治疗的强大工具,包括乳腺癌.

研究的目的:

为提供乳腺癌内免疫治疗的综合性审查.
检查这些疗法对瘤微环境的影响.
通过完成的临床试验来评估各种免疫治疗药物的疗效.

主要方法:

关于乳腺癌内免疫治疗的当前文献的综述.
对不同免疫治疗剂的分析:瘤病毒,核酸,先天免疫激动剂,细菌,CAR T细胞和树突细胞.
对乳腺癌患者这些疗法的临床试验数据的评估.

主要成果:

内免疫疗法可以通过改变瘤微环境来诱导局部抗瘤免疫反应.
各种免疫疗法在乳腺癌的临床前和临床环境中都显示出潜在的潜力.
了解瘤微环境调制是提高免疫治疗疗效的关键.

结论:

内免疫疗法代表了乳腺癌治疗的重大进步,特别是对于耐药和转移性疾病.
进一步的研究和临床试验对于优化这些策略和改善患者治疗结果至关重要.
未来的前景集中在完善免疫治疗方法和乳腺癌的组合策略.

关键词:

乳腺癌乳腺癌乳腺癌树突细胞疫苗的使用.免疫疗法免疫疗法瘤微环境是一个微环境.

更多相关视频

Orthotopic Injection of Breast Cancer Cells into the Mice Mammary Fat Pad

Orthotopic Injection of Breast Cancer Cells into the Mice Mammary Fat Pad

Published on: January 20, 2019

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.